Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 551,155 | 760,417 | 594,967 | 543,100 | 81,490 | 36,821 |
| Cost of revenue | 202,743 | 547,785 | 871,333 | 404,817 | 42,404 | 43,543 |
| Gross profit | 348,412 | 212,632 | −276,366 | 138,283 | 39,086 | −6,722 |
| Research and development | 449,834 | 755,944 | 531,170 | 533,587 | 424,579 | 566,568 |
| Selling, general and administrative | 1M | 1M | 1M | 942,440 | 644,634 | 822,818 |
| Operating expenses | 5M | 5M | 4M | 4M | 3M | 3M |
| Operating income | −5M | −4M | −5M | −4M | −3M | −3M |
| Pre-tax income | −5M | −4M | −5M | −4M | −3M | −3M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −5M | −4M | −5M | −4M | −3M | −3M |
| Earnings per share, diluted | −0.26 | 0.03 | −0.03 | −0.03 | 0.02 | −0.02 |
| Weighted average shares, diluted | 17M | 151M | 145M | 145M | 133M | 133M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 447,453 | 3M | 933,328 | 2M | 7M | 11M | 2M | 5M |
| Receivables | 2M | 668,903 | 643,585 |
| Metric | 31/03/2026 | 31/03/2025 | 30/06/2024 |
|---|---|---|---|
| Operating cash flow | −3M | −3M | — |
| Depreciation and amortisation | 209,315 | 164,004 | — |
| Share-based compensation | 1M | 709,463 | 275,384 |
| Capital expenditure | 345,949 | 297,322 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 863,819 |
| 94,103 |
| 269,733 |
| 288,777 |
| 57,437 |
| Inventory | 2M | 1M | 2M | 2M | 2M | 2M | 1M | 1M |
| Current assets | 5M | 6M | 6M | 8M | 12M | 15M | 6M | 9M |
| Property, plant and equipment | 4M | 4M | 3M | 3M | 3M | 3M | 278,786 | 260,154 |
| Total assets | 11M | 11M | 11M | 12M | 16M | 19M | 10M | 12M |
| Current liabilities | 4M | 4M | 4M | 3M | 3M | 3M | 2M | 2M |
| Total liabilities | 7M | 5M | 5M | 3M | 3M | 4M | — | 2M |
| Equity | 4M | 7M | 6M | 9M | 13M | 15M | 8M | 11M |
| Shares outstanding | 17M | 17M | 154M | 146M | 145M | 14M | 133M | 133M |
| Shares issued | 17M | 17M | — | — | 145M | 14M | 133M | 133M |
| Investing cash flow | −345,949 | −297,322 | — |
| Financing cash flow | 103,061 | 24,000 | — |